Navigation Links
Caesareans In U.S. At All-Time High

The rate of Caesarean sections in the US has climbed to an all-time high, despite efforts to bring them down.

According to the National Center for Health Statistics, about 1.2 million C-sections were performed in 2004—29.1 // percent of all births that year, up from 27.5 percent in 2003 and 20.7 in 1996.

The C-section rate increased for all births, even those that involved healthy, first-time pregnancies with a full-term, single child. The government announced in 2000 a national public health goal of reducing the C-section rate for such births to 15 percent by 2010, but the actual rate now is 24 percent, and is on the increase.

The increase is attributed to fears of malpractice lawsuits in the event of a vaginal delivery going wrong, preferences of mothers and physicians, and the risks of attempting vaginal births after Caesareans.

A C-section is major surgery which involves cutting open a women's abdomen to retrieve the baby. The risks include infection and, in rare cases, death. The recovery time is longer than with a vaginal delivery. It is performed when the fetus lacks oxygen or is in life-threatening distress.

For decades, C-sections were done only in fewer births. In 1970, it was as low as 5 percent. By the mid-1980s, it exceeded 20 percent. This was because mothers increasingly preferred the convenience of C-sections, which could be scheduled, and technological innovations enabled doctors to better see the problems before birth.

By the late 1990s, health insurers had cut back their C-section control efforts. Also, studies that showed that women who deliver vaginally after having a C-section earlier suffer a ruptured uterus — a potentially lethal complication for both mother and child — in about 1 percent of such cases, worried doctors. Some hospitals have banned vaginal deliveries after C-section, or VBAC. The VBAC rate has dropped to 9.2 percent of births after a previous Caesarean in 2004, c ompared with 28.3 percent in 1996.

The rate of Caesareans among women who have not previously had one has shot up, climbing to 20.6 percent of such births in 2004, compared with 19.1 percent in 2003 and 14.6 in 1996.

On the Net: C-section report:

http://www.cdc.gov/nchs'"/>




Related medicine news :

1. Women warned against Caesareans
2. Skilled Obstetricians to avoid unnecessary Caesareans
3. Doctors Warned Against Encouraging Elective Caesareans
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: